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Abstract
Background
When an incurable fetal condition is detected, some women (or couples) would rather
choose to continue with the pregnancy than opt for termination of pregnancy for medical
reasons, which, in France, can be performed until full term. Such situations are frequently
occurring and sometimes leading to the implementation of neonatal palliative care. The ob-
jectives of this study were to evaluate the practices of perinatal care french professionals in
this context; to identify the potential obstacles that might interfere with the provision of an
appropiate neonatal palliative care; and, from an opposite perspective, to determine the cri-
teria that led, in some cases, to offer this type of care for prenatally diagnosed
lethal abnormality.
Methods
We used an email survey sent to 434 maternal-fetal medicine specialists (MFMs) and fetal
care pediatric specialists (FCPs) at 48 multidisciplinary centers for prenatal diagnosis
(MCPD).
Results
Forty-two multidisciplinary centers for prenatal diagnosis (87.5%) took part. In total, 102
MFMs and 112 FCPs completed the survey, yielding response rate of 49.3%. One quarter
of professionals (26.2%) estimated that over 20% of fetal pathologies presenting in MCPD
could correspond to a diagnosis categorized as lethal (FCPs versus MFMs: 24% vs 17.2%,
p = 0.04). The mean proportion of fetal abnormalities eligible for palliative care at birth was
estimated at 19.30% (± 2.4) (FCPs versus MFMs: 23.4% vs 15.2%, p = 0.029). The degree
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of diagnostic certainty appears to be the most influencing factor (98.1%, n = 207) in the in-
formation provided to the pregnant woman with regard to potential neonatal palliative care.
The vast majority of professionals, 92.5%, supported considering the practice of palliative
care as a regular option to propose antenatally.
Conclusions
Our study reveals the clear need for training perinatal professionals in perinatal palliative
care and for the standardization of practices in this field.
Introduction
Inherited major structural or genetic abnormalities affect around 3% of births [1,2] and are one
of the primary causes of infant morbidity and mortality. Some of these conditions are incom-
patible with long-term survival after birth [3]. It is not always possible to predict lethality, even
in a fetus presenting severe abnormalities, and it is rare to have cases of long-term survivors
with a severe disability [3]. French law [4] stipulates that, at the pregnant woman's request, ter-
mination of pregnancy for medical reasons (TOP) may be performed until full term provided
that two doctors from a multidisciplinary team confirm either that continuing with the preg-
nancy would put the mother’s health at serious risk, or that there is a high probability that the
unborn child will have a particularly serious condition already recognized as incurable at the
time of antenatal diagnosis. In this situation, some women decide to continue with the preg-
nancy [5].
There has been much work published on strategies for managing pregnancies with lethal
fetal abnormalities based on the expert opinions [6–11]. While many "recommendations" ad-
vise what perinatal professionals should do [6], there is only little data on what professionals
actually do in practice. It is therefore important that multidisciplinary teams analyze and evalu-
ate their professional practices. Our recent qualitative research [12] revealed the place accorded
to the concept of neonatal palliative care and confirmed that these practices take into account
multiple factors (professional, information-related, human and ethical), which question the
fundamentality of multidisciplinary approach. However, consistency between antenatal and
postnatal care teams, involving joint discussion, appears essential in order to guarantee conti-
nuity of care and respect the process of parenthood [11]. In order to be able to standardize the
practices at a national level, we needed to review the opinions and practices at multidisciplinary
centers for prenatal diagnosis (MCPD). Based on these findings, we put our primary objective
to evaluate the practices of perinatal care professionals in France in the domain of palliative
care. As secondary objective, we sought to identify the potential barriers to the routine offering
of neonatal palliative care; and, from an opposite perspective, to determine the criteria that
contributed to offer this type of care in cases of prenatally diagnosed lethal abnormality.
Materials and Methods
The research team designed the questionnaire and conducted the survey using electronic re-
minders (three reminders) between April 2012 and December 2012. Ethical approval was ob-
tained from the University Hospital ethics committee of Marseille, France; and the French
Advisory Committee for Information Processing in Health Research expressed a favorable
opinion of the performance of this research (reference number: 12.154).
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Sample and List Development
We used a database provided by MCPD (a master file available via the website of each center)
to conduct a national survey concerning all perinatal professionals working in MCPD in
France. We began by identifying all fetal care and fetal treatment centers from national listings
of related research centers, professional organizations, and children’s hospitals. We searched in
the websites and physician directories to reach the pediatric subspecialists providing fetal diag-
nostic or treatment services in those centers. We made additional Internet searches and tele-
phone calls to the centers for confirmation. The resulting file contained 434 email addresses
from 48 MCPD. Two groups of perinatal professionals were identified: maternal fetal medicine
specialists (MFMs) in obstetric gynecology, midwifery or psychology; and fetal care pediatric
specialists (FCPs) in neonatology, pediatric intensive care or genetics.
Survey Instrument Development
We developed the questionnaire following a qualitative study using focus groups from two
French multidisciplinary centers for prenatal diagnosis [12]. The final survey instrument con-
sisted of 12 pages, comprising 3 parts: (1) Sociodemographic and professional characteristics
(i.e. age, gender, professional status, seniority in the profession and in MCPD); (2) Opinions
on lethal fetal abnormalities, neonatal palliative care and their management (i.e. definitions
and perceptions of neonatal palliative care: definition of lethal fetal abnormality (LFA), per-
ceived difficulties concerning LFA diagnosis and prognostic, perceived proportion of LFA, ex-
istence and usefulness of a LFA list, training in palliative care, opinions toward palliative care
in neonatal period); and (3) Practices related to lethal fetal abnormalities and neonatal pallia-
tive care (i.e. criteria influencing management of LFA, criteria influencing antenatal communi-
cation of information about palliative care). A final draft questionnaire was pretested on 5
physicians (neonatologists and obstetricians) from the target eligible group to determine ease
of understanding and completion time. Self-administered pretests take approximately 20 min-
utes. The questionnaire was posted online (via a private website created for the study) on April
2012 for a period of 9 months. Three email reminders were sent during this period. Completed
questionnaires were automatically sent to an email address created for the study. Anonymity
was strictly respected.
Statistical Analysis
Descriptive data were expressed as numbers and percentages, supplemented with the corre-
sponding means and standard deviations (SD) when applicable. Comparison of variables be-
tween the two groups of specialists was made using the chi-square test or analysis of variance,
depending on the type of variable. Non-parametric tests were applied for variables with non-
normal distribution. The threshold of significance of the tests was fixed at 5%. Statistical analy-
ses were carried out using SPSS version 18 software.
Results
Forty-two MCPD (87.5%) took part in the study. In total, 102 MFMs and 112 FCPs completed
the survey, yielding response rate of 49.3%, and a mean of 5 professionals from each MCPD.
Table 1 shows the characteristics of the professionals.
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Clinical Experiences and Professional Attitudes towards Lethal Fetal
Conditions
The majority of professionals (97.7%, n = 209) considered the purpose of antenatal diagnosis
as part of a curative care plan for the fetus, an attitude particularly prevalent among MFMs.
Professionals generally considered that the MCPD has a duty to provide women with advices
and information (96.7%, n = 207). Table 2 shows and compares the definitions and perceptions
of lethal fetal abnormality (LFA) as reported by perinatal professionals. In total, 26.2% (n = 46)
of professionals estimated that over 20% of fetal abnormalities presenting in MCPD could be
categorized as lethal. The mean estimated proportion of LFA was more elevated among FCPs
than MFMs (MFMs vs FCPs, 17.2% and 24.0% respectively (p = 0.04)). The procedures to be
followed when managing lethal fetal abnormalities (trisomy 18, severe or syndromic diaphrag-
matic hernia, anencephaly, severe hydrocephalus, bilateral renal agenesis) were varied. More
than half of the professionals considered TOP to be the appropriate course of action for triso-
my 18 (50.1%, n = 112) and anencephaly (55.6%, n = 119). Neonatal palliative care was consid-
ered the appropriate strategy for severe hydrocephalus (11.5%, n = 24) and bilateral renal
agenesis (20.1%, n = 43).
Neonatal Palliative Care Procedures
Nearly half of the professionals surveyed (47.8%, n = 98) reported that they had received practi-
cal training in palliative care—this being more common among FCPs (59.6% vs 34.4%,
p< 0.001)—while one quarter (n = 54) had received theoretical formation.
Palliative care, defined as “active and continuous care provided by a multidisciplinary team
in an institution or at home. It is intended to relieve pain, reduce mental suffering, preserve the
Table 1. Sociodemographic characteristics of the participating professionals.
Characteristics Total n = 214 MFMs (%), n = 102 FCPs (%), n = 112 P value
Age, y
Mean ± SD 41.9 ± 11.7 43.2 ± 11.0 40.6 ± 12.2 NS
Sex
Male 65 (30.4) 23 (22.5) 42 (37.5) 0.018
Female 149 (69.6) 79 (77.5) 70 (62.5)
Role
Obstetric Gynecologist 61 (28.5) 61 (59.8) ― ―
Midwife 36 (16.8) 36 (35.2) ― ―
Psychologist 5 (10.6) 5 (4.9) ― ―
Neonatologist 58 (27.1) ― 58 (51.8) ―
Pediatric and neonatal intensive care specialist 40 (18.6) ― 40 (35.7) ―
Geneticist 8 (3.7) ― 8 (7.1) ―
Other 6 (2.8) ― 6 (2.8) ―
Professional Experience, years
< 10 y 89 (41.6) 39 (38.6) 50 (45.5) NS
 10 y 122 (57.0) 62 (61.4) 60 (54.5)
Total Professional Experience in MCPD, months
< 60 m 62 (36.7) 20 (24.4) 42 (48.3) 0.001
 60 m 107 (63.3) 62 (75.6) 45 (51.7)
MFMs: Maternal Fetal Medicine specialists; FCPs: Fetal Care Pediatric specialists; MCPD: Multidisciplinary Center for Prenatal Diagnosis.
doi:10.1371/journal.pone.0126861.t001
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patient's dignity and support their family and friends" [13], was provided as such by nearly 80%
(n = 157) of the professionals and particularly by FCPs (MFMs: 66.7% vs FCPs: 90%,
p< 0.001). The mean proportion of fetal abnormalities eligible for palliative care was estimated
at 19.3% (± 2.4), with this figure significantly differing between MFMs and FCPs (15.2% vs
23.4% respectively, p = 0.029). Of the professionals surveyed, 20.5% (n = 35) estimated that
over 20% of fetal abnormalities could result in the provision of palliative care after birth.
Table 3 reports the definitions and perceptions of neonatal palliative care declared by
the professionals.
Barriers to and Influences on Perinatal Palliative Care
The most significant factor contributing to the decision to continue with the pregnancy follow-
ing the diagnosis of a lethal fetal abnormality was "to respect parental freedom of choice (their
autonomy)", as reported by quitely over half of professionals (56.0%, n = 120). From an
Table 3. Definitions and perceptions of neonatal palliative care.
MFMs, n
%
FCPs, n
%
P
value
The implementation of palliative care signiﬁes withholding certain
curative care options in the neonatal period.
56 (56.6) 63 (57.3) NS
Neonatal palliative care is care intended to provide end-of-life
support for patients.
90 (90.9) 72 (64.9) <
0.001
Provision of palliative care to a neonate is fundamentally analogous
to that provided to other patients.
59 (59.6) 47 (42.3) 0.013
The legal framework for the provision of adult palliative care should
be different than that of neonates.
46 (51.7) 66 (60.0) NS
The term "palliative care" is appropriate to use for neonates. 80 (81.6) 79 (71.2) NS
The provision of palliative care amounts to "concealed euthanasia". 18 (18.2) 16 (14.3) NS
Palliative care plans can be considered as an "alternative" to TOP. 86 (87.8) 80 (71.4) 0.004
Rate signiﬁes the percentage of professionals who agreed with the statement made.
doi:10.1371/journal.pone.0126861.t003
Table 2. Definitions and perceptions of lethal fetal abnormality (LFA) reported by perinatal professionals.
MFMs, n% FCPs, n% P value
How can we describe LFA? *
Short life expectancy of the newborn 90 (89.1) 103 (94.5) NS
Certainty of neonatal death 83 (83.0) 92 (84.4) NS
No reasonable therapeutic options available 77 (77.0) 90 (82.6) NS
Diagnosis and prognosis of LFA:
Difﬁculty in diagnosing LFA 73 (73.7) 94 (85.5) 0.035
Prognostic uncertainty of LFA 29 (29.0) 37 (33.9) NS
Proportion of fetal abnormalities presenting in MCPD corresponding to LFA:
(mean ±SD) 17.2 ± 19.3 24 ± 23.5 0.040
Does your MCPD have an LFA list?
No 63 (62.4) 43 (38.7) < 0.001
Don't know 33 (32.7) 65 (58.6)
Usefulness of an LFA list in practice at the MCPD 49 (49.0) 65 (58.6) NS
*only 3 options were given to the professionals.
doi:10.1371/journal.pone.0126861.t002
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opposite perspective, in one fourth of cases (25.7%, n = 55), the least important factor was "to
achieve parental acceptance of the diagnosis of lethal abnormality in case of initial refusal ". Ta-
bles 4 and 5 show the factors that influence the management of lethal fetal abnormalities
(Table 4) and point out the obstacles that interfere with providing adequate information about
palliative care at birth (Table 5). The notion of "the presumed quality of the baby's life given its
condition" seems to have the most influence on the professionals' course of action (97.1%,
n = 204). The "degree of diagnostic certainty" appears to be the most important part (98.1%,
Table 4. Categorization of factors that influence perinatal professionals whenmanaging cases of lethal fetal abnormality.
Rank MFMs (%), FCPs (%), P value
The presumed quality of the baby's life given its condition 1 99 (100.0) 105 (94.6) 0.031
The religious values of the future parent(s) 2 96 (96.0) 108 (97.3) 0.71
The degree of diagnostic certainty 3 97 (97.0) 106 (96.4) 1.000
The couple's request for a particular type of management 4 95 (96.9) 107 (96.4) 1.000
The moral values of the future parent(s) 5 93 (93.9) 108 (97.3) 0.312
The antenatal information provided about the various management options, including PC 6 96 (97.0) 99 (90.8) 0.087
The understanding level of the future parent(s) 7 92 (94.8) 99 (90.0) 0.297
The level of evidence of the information given to the couple about the condition 8 94 (94.0) 95 (87.2) 0.105
The degree of conﬁdence of the future parent(s) in the MCPD team 9 88 (88.0) 88 (81.5) 0.193
The presumed duration of the baby's survival given its condition 10 87 (88.8) 88 (81.5) 0.144
The extent of the team's experience in palliative care 11 86 (87.8) 87 (78.4) 0.073
The stage of pregnancy 12 70 (71.4) 89 (81.7) 0.099
The possibility of "sparing suffering" by performing TOP 13 63 (63.6) 57 (51.8) 0.094
The socio-economic and cultural context of the future parent(s) 14 43 (43.0) 65 (59.1) 0.020
P-Value for Pearson’s χ2 testing independence between groups of perinatal professionals (maternal fetal medicine specialists, MFMs; fetal care pediatric
specialists, FCPs) and the opinion toward the factors that inﬂuence LFA (initially collected from a 4-point scale, opinions were recoded in a binary variable:
scores from 1 to 2 represented lack of inﬂuence and scores from 3 to 4 represented the inﬂuence of the factor).
doi:10.1371/journal.pone.0126861.t004
Table 5. Categorization of items influencing antenatal information about palliative care in cases of lethal fetal abnormality.
Rank MFMs (%), FCPs (%), P value
The degree of diagnostic certainty 1 96 (97.0) 111 (99.1) 0.256
The couple's request concerning management 2 97 (98.0) 105 (93.8) 0.129
The quality of the relationship between antenatal and postnatal teams 3 93 (93.0) 102 (91.9) 0.761
The understanding level of the future parents 4 94 (93.1) 100 (90.1) 0.437
The experience and level of expertise of the team responsible for palliative care within the hospital 5 93 (92.1) 97 (87.4) 0.263
The possibility of suggesting a meeting with the neonatal palliative care team 6 93 (93.0) 95 (86.4) 0.117
The legal framework 7 87 (87.0) 96 (85.7) 0.786
The opinions of the MCPD group 8 79 (78.2) 94 (83.9) 0.287
The opinions of the antenatal care team on TOP and palliative care 9 75 (74.3) 89 (80.2) 0.303
The limitations and variability of perceptions of the care team 10 68 (68.7) 85 (77.3) 0.162
The socio-cultural characteristics of the future parents 11 65 (65.0) 79 (71.2) 0.336
The unease of care providers in dealing with death 12 66 (66.0) 76 (67.9) 0.774
P-Value for Pearson’s χ2 testing independence between groups of perinatal professionals (maternal fetal medicine specialists, MFMs; fetal care pediatric
specialists, FCPs) and the opinion toward the factors that inﬂuence antenatal communication of information about palliative care at birth in cases of lethal
fetal abnormality (initially collected from a 4-point scale, opinions were recoded in a binary variable: scores from 1 to 2 represented lack of inﬂuence and
scores from 3 to 4 represented the inﬂuence of the factor).
doi:10.1371/journal.pone.0126861.t005
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n = 207) in the information provided to the woman with regard to potential palliative
management.
Professionals opinions were generally in favor (92.5%, n = 197, 94.1% and 91% among
MFMs and FCPs respectively) of standardizing the practice of offering women the option of
neonatal palliative care (in cases of lethal fetal abnormalities). Lastly, 64.6% (n = 135) of profes-
sionals supported, in certain circumstances, offering TOP without feticide with palliative care
at birth.
Discussion
Our study shows and accurately evaluates how LFA is defined and perceived by perinatal pro-
fessionals, its impact on the information provided to parents (mainly regarding palliative care
at birth), and the obstacles interfering with taking palliative care into consideration. In addition
to this, our study was conducted on a non consensus opinion model at professional and nation-
al level. Moreover, it is the first study to evaluate the attitudes and opinions toward perinatal
palliative care (PPC) in a national survey in France. It highlights the different factors (e.g., pro-
fessional anticipations, uncertainty, psychosocial characteristics of parents) that affect the man-
agement of LFA in the French context. Its outcome can potentially be a first step toward
creating a more global framework for PPC in France.
Our French national survey reveals the variation in perceptions and practices among MFMs
and FCPs regarding the approach to pregnancy complicated by LFA. More specifically, it
shows discrepancies in professional opinions of pediatric specialists concerning clinical, legal
and ethical aspects of prenatal diagnosis of lethal fetal abnormality. This research satisfies the
requirements for transparency set out by the Leonetti Law [14], supported by the French Neo-
natology Society [15]. It also satisfies the recommendations issued by national observatories
and commissions on end-of-life and palliative care [16,17], and these recommendations under-
lined the need for a such research in this area, as already undertaken in other countries [18].
Even so, this study has its limitations. The limited participation rate could be explained by
the length of questionnaire, but it is similar to the usual rate in qualitative pediatric studies
[19]. Besides, there could be other reasons. We hypothesize that PPC, a relatively new area in
neonatology, might conflict with personal convictions and the complexity of management of
such pregnancies [12]. Some doctors also stated that their non-participation was due to a lack
of knowledge in this area. It is recognized in the survey that the recruited sample does not rep-
resent the entire population but only a sample of people who agreed to participate in the study.
Our data should be weighted due to intra-individual variability [20].
We report a paradoxical response rate concerning diagnostic and prognostic certainty in
LFA. Ideally, PPC is offered when there is both diagnostic and prognostic certainty, but occa-
sionally it is also offered in some cases of prognostic certainty with diagnostic uncertainty. Usu-
ally it is inappropriate to provide PPC when there is prognostic uncertainty, at least until
neonatal examination and investigations are done [2]. Due to the fact that French law does not
list the fetal abnormalities where TOP is allowed (however, it is almost impossible to have a
such list due to continuous advances in knowledge), there is a considerable variability among
physicians in assessing the legitimacy of pursuing the pregnancy. Even the term "lethal fetal ab-
normality" is controversial; "life-limiting condition" would be more appropriate [3]. Dommer-
gues et al have assessed the cases of fetal abnormalities resulting in termination of pregnancy,
and one of the aims of their study was to determine what degree of severity in such fetal condi-
tions would result in TOP in France [21]. These authors considered lethal every condition in
which the risk of perinatal or infant mortality has been estimated at over 90%, such as anen-
cephaly. In response to this mentioned study and its outcome, Bétrémieux makes clear that
Barriers in Referring Neonatal Patients to Perinatal Palliative Care
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33% of the TOP described there were carried out in a context of lethal fetal condition. In
France, there are around 8,000 terminations of pregnancy per year; so there are 2,500 termina-
tions due to lethal fetal abnormality [22]. In 2012, 810 women chose to continue with their
pregnancy in spite of the diagnosis of severe fetal abnormality to which, if ever requested, TOP
could have been performed [23].
In this context, we think that it has become essential to develop, like in many other coun-
tries, a framework or guidelines for PPC. In the UK, the National Screening Committee provid-
ed guidance on the proportion of cases of structural and chromosomal abnormalities that it
expects to detect (NHS 2010), and the International Society of Ultrasound in Obstetrics and
Gynecology provides guidelines on the conduct of both screening and more targeted fetal ultra-
sound examinations in order to detect structural fetal anomalies [24]. Most of lethal structural
abnormalities may be detected at 18–22 weeks. In this context, the British Association of Peri-
natal Medicine developed a Framework for PPC [8]. It indicates some of the clinical scenarios
in which eligibility for palliative care could be considered. Our study reports that the level of di-
agnostic certainty is the most important criteria guiding the information provided to parents
concerning potential need for neonatal palliative care. However, professionals cannot avoid the
uncertainty due to limitations in the antenatal examination, the latter being fundamental for
making a certain diagnosis and a reliable prognosis prior to birth. The women (or couples) also
need to be informed about the limits of medical knowledge in general and the prenatal diagno-
sis in particular. Most of prenatal diagnoses that are deemed lethal need to be confirmed at
birth [25].
Palliative care (as defined by French law [13]) is perceived differently by professionals. Less
than half of the surveyed professionals had received practical training in palliative care and one
quarter had received theoretical formation. Yet, in France, more than half of neonatal deaths
followed decisions to limit and/or cease active treatment, and, therefore, fell under the category
of palliative care [26]. The majority of professionals (less among FCPs) consider neonatal palli-
ative care as care intended to provide end-of-life support for patients, and it can be considered
as an "alternative" to TOP. The core intention of providing postnatal palliative care where the
infant is brought to life surely differs from that of TOP where the fetus is to die.. Therefore, pal-
liative support for a newborn can never simply be considered as an option or an alternative to
TOP. It is not a matter of choosing between two different treatments for the same disease but
choosing between two different intentions, belonging to two different episodes of time. The
provision of palliative care is of an open and uncertain duration during which the well-being of
the infant and their family is the priority; unlike TOP, which is "faster", "drastic", and per-
formed according to a protocol [11].
This study highlighted the difficulties and discrepancies related to PPC in various domains
of perinatal care. Notably, the difficulties associated with defining and diagnosing LFA remain
an obstacle to the provision of information (in terms of both content and method of communi-
cation) and the implementation of PPC. In an antenatal context, identifying "unreasonable ob-
stinacy" (or "futility"), the first step in implementing palliative care [27], is therefore
problematic, with the concept often appearing vague or prospective (the anticipation of unrea-
sonable obstinacy of treatment in a neonatal context). In other words, prognostic (and/or sci-
entific) uncertainty constitutes an important factor in terms of choice of the approach and it
can strengthen the possibility of choosing the first option: TOP. Resorting to TOP, in this con-
text, could be considered as a norm, a norm strongly induced by uncertainty [12]. TOP without
feticide drug prior to 24 weeks is another option, an option that enables the woman to avoid
participating in fetal death and, sometimes, allowing her to meet her baby alive in the delivery
room where palliative care is implemented [28]. Conversely, if the woman or couple is more
tolerant toward this medical uncertainty, they will more likely continue with the pregnancy.
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PLOS ONE | DOI:10.1371/journal.pone.0126861 May 15, 2015 8 / 11
Medical uncertainty allows them to fantasize that the child might be healthy at birth and that
after all the diagnosis could be a mistake. The future parents may believe in the idea of "love
that conquers all", and feel the need to prove it to the medical team. This uncertainty must be
incorporated by the perinatal professionals in their provision of care; they must share it, accept
it, understand its risks, and accordingly develop care strategies in collaboration with the
woman or the couple. While this uncertainty is perceived as a limiting factor by medical team,
it is actually the power that drives the woman or couple to continue with the pregnancy. Thus
parents report a positive experience with PPC programs [29] where a specific detailed plan is
provided determining the values and objectives of this type of care, recognizing the needs of
both the patient and their family, and ensuring the presence of a multidisciplinary team trained
in PPC working in an environment that is physically and environmentally adapted to meet
these needs [30]. Furthermore, it would be useful to evaluate women’s motivation when taking
their decision after announcement of the diagnosis. We need to find out if the variation of atti-
tudes and perceptions among perinatal professionals would affect women's decisions about the
pregnancy [31], and specially their decisions about termination of pregnancy due to lethal ab-
normality. In addition, this study demonstrates a clear need for providing PPC training for
professionals and for standardizing PPC practices, and this would be facilitated by creating a
PPC framework in France as it already exists in UK [8,9]. According to our outcomes, the
woman's autonomy and freedom of choice are important concepts. Agreeing with this, the
American College of Obstetricians and Gynecologists-Committee on Ethics and the American
Academy of Pediatrics-Committee on Bioethics [10], along with the British Association of
Perinatal Medicine [8] have all made recommendations for physicians dealing with families
who are expecting a baby with lethal hereditary malformation, and they also focused on the im-
portance of discussion: "The informed consent process should involve thorough discussion of
the risks and benefits for both the fetus and the pregnant woman. The full range of options, in-
cluding fetal intervention, postnatal therapy, palliative care, or pregnancy termination, should
be discussed". French guidelines also contributed to the content of this discussion [6,14].
Eventually, consent (which is directly attributed to the information provided), although re-
sulting from a legal obligation, raises some pertinent questions. How much freedom does the
woman really have in choosing? Isn’t the situation itself imposing an inevitable decision? Is
free choice possible given the pressure upon her (or the future parents) from medical profes-
sionals and/or society? In conclusion, given that 92.5% of the investigated perinatal profession-
als agreed with always informing the women about the option of neonatal palliative care in
cases of lethal fetal abnormality, it is therefore essential to discuss and provide a framework for
implementation of PPC.
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